Tag Archives: Tom Price

Trump offloading drug price battle to new FDA chief; Dr. Gottlieb’s ideas make a lot of sense






The News: New FDA Commissioner Dr. Scott Gottlieb comes into office immediately confronted by a host of tough challenges: from budget concerns, drug prices, staffing issues and a nationwide opioid… Read more »

Senate confirms Gottlieb as FDA chief; former FDA tour, industry ties signal solid choice despite Dems’ jabs






The News: The US Senate voted 57 to 42 on Tuesday (May 9, 2017) to confirm Scott Gottlieb, MD, as Food and Drug Administration (FDA) Commissioner. Gottlieb, who was nominated by… Read more »

NIH proves immune to Trump’s budget scalpel






The News: Lawmakers expanded instead of slashed the budget for the National Institutes of Health (NIH) in its bipartisan deal to fund the government earlier this week, essentially snubbing the… Read more »

GOP can’t handle the truth: millions to lose coverage under Trumpcare






Steve’s Take: Remember President Trump’s pre- and post-election promise, no, it sounded more like a guarantee, of “insurance for everybody?” Then last week, the Trump-backed House bill, when finally unveiled… Read more »

Trumpcare slowly imploding; perhaps morphing into Obamacare 2.0?






Steve’s Take: Six years after its passage, the Affordable Care Act has demonstrated it’s far from perfect. But replacing such an immense, complicated law on an accelerated schedule is presenting… Read more »

Humana bails Obamacare exchanges; signals beginning of the end of private insurer involvement






The News: Humana Inc. (Louisville KY) said it will leave the commercial individual insurance business effective in 2018, including coverage offered on public exchanges under the Affordable Care Act, after being unable to… Read more »

Trump backs negotiating drug prices under Medicare; unless he doesn’t






The News: President Donald Trump supports Medicare drug price negotiations, his spokesman said last week, remarks that sent pharmaceutical stocks swinging again as investors tried to assess whether drugmakers will… Read more »

Trump’s HHS cabinet pick eludes Congress’s Q&A about Trumpcare specifics; questionable stock investments obscure his suitability to run the US health show






The News: Georgia Rep. Tom Price, President Trump’s choice for secretary of the Department of Health and Human Services, on Tuesday rejected conflict of interest and abuse of power accusations related to… Read more »

Trump scorns Pharma, calls for drug pricebidding; stocks swoon on latest pivot, but does the POTUS-elect mean it?






President-elect Donald Trump on Wednesday (January 11, 2017) pledged to change the way the federal government purchases prescription drugs, a striking, largely unforseen warning to the drug industry that he… Read more »